2-Minute Neuroscience: Facial Nerve (Cranial Nerve VII)

| March 28, 2019

article image
The facial nerve (cranial nerve VII) has multiple functions, but is best known for its role in controlling the muscles of facial expression. In this video, I cover all of the functions of the facial nerve, as well as describe what can happen when the nerve is damaged.

Spotlight

A Plus Home Health Care, Inc.

A Plus Home Health Care, Inc. empowers people needing in-home care to live healthier, longer, more independent lives by providing customized, consistent and exceptional service. Our customized service includes protocols for Congestive Heart Failure, Behavioral Health, Alzheimer’s and Diabetic Care to name a few. We provide our services in a consistent manner by employing nurses and therapists of the highest caliber whom work for us full time - so patients maintain a continuity of care unequaled in the industry. A Plus also maintains a 100% track record in beginning patient care in a timely manner.

OTHER ARTICLES

Pfizer, BioNTech Plan Clinical Trial for COVID-19 mRNA Vaccine Candidate

Article | April 9, 2020

Pfizer and BioNTech plan to begin human clinical trials on their lead COVID-19 therapeutic candidate, an mRNA vaccine, by the end of this month, the companies said today, through a collaboration that could generate up to $748 million for the German biotech. The companies announced plans last month to partner on BNT162, the first treatment to emerge from BioNTech’s accelerated COVID-19-focused development program, “Project Lightspeed.” BioNTech and Pfizer established collaboration intended to draw upon BioNTech’s proprietary mRNA vaccine platforms, and Pfizer’s expertise in vaccine research and development, regulatory capabilities, and global manufacturing and distribution network.

Read More

Selexis Cell Line Development Strategies

Article | February 11, 2020

In today’s biotechnology landscape, to be competitive, meet regulations, and achieve market demands, “we must apply Bioprocessing 4.0,” said Igor Fisch, PhD, CEO, Selexis. In fact, in the last decade, “Selexis has evolved from cloning by limiting dilution to automated cell selection to nanofluidic chips and from monoclonality assessment by statistical calculation to proprietary bioinformatic analysis,” he added. Single-use processing systems are an expanding part of the biomanufacturing world; as such, they are a major component of Bioprocessing 4.0. “At Selexis, we use single use throughout our cell line development workflow. Currently, we have incorporated single-use automated bioprocessing systems such as ambr® and the Beacon® optofluidic platform for accelerated cell line development. By using these systems and optimizing our parameters, we were able to achieve high titers in shake flasks. Additionally, the Beacon systems integrate miniaturized cell culture with high-throughput liquid handling automation and cell imaging. This allows us to control, adjust, and monitor programs at the same time,” noted Fisch.

Read More

Wisconsin biotech companies could play key roles in long-term economic recovery from COVID-19 pandemic

Article | April 19, 2020

Whether it’s called a modern “Manhattan Project” or a medical moon shot, the concept of long-term economic recovery rests on how confident people are they won’t risk serious illness by venturing forth in public again. Wisconsin stands to be a significant part of such an undertaking, whatever it’s called. The shorter-term debate is well under way over the gradual lifting of COVID-19 emergency rules, such as the now-extended “safer-at-home” order in Wisconsin. At least a dozen states, including regional coalitions on the East and West coasts, are exploring next steps as they seek to balance responses to the virus with calls for reopening the economy, at least, in part. Wisconsin’s ability to shape longer-term responses will come from private and public resources, which range from companies engaged in production of diagnostics.

Read More

Ruminating on Bioprocessing 4.0

Article | February 18, 2020

The Bioprocessing 4.0 concept seeks to apply automation and technology to the digital transformation of biologics manufacturing. As the paradigm moves forward, it faces barriers to its adoption, according to Eric Langer, president of BioPlan Associates. “Perhaps the greatest challenges involve unsecured links and adapting the applications to areas where automation is critically needed today,” says Langer. “Unresolved security issues could seriously affect a company’s data in a regulated environment, so they will need to have iron-clad anti-hacking protection in place. Unfortunately, cyber security is not yet a top focus for the industry.”

Read More

Spotlight

A Plus Home Health Care, Inc.

A Plus Home Health Care, Inc. empowers people needing in-home care to live healthier, longer, more independent lives by providing customized, consistent and exceptional service. Our customized service includes protocols for Congestive Heart Failure, Behavioral Health, Alzheimer’s and Diabetic Care to name a few. We provide our services in a consistent manner by employing nurses and therapists of the highest caliber whom work for us full time - so patients maintain a continuity of care unequaled in the industry. A Plus also maintains a 100% track record in beginning patient care in a timely manner.

Events